These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 19003798)

  • 1. First trimester maternal serum PAPP-A, beta-hCG and ADAM12 in prediction of small-for-gestational-age fetuses.
    Pihl K; Larsen T; Krebs L; Christiansen M
    Prenat Diagn; 2008 Dec; 28(12):1131-5. PubMed ID: 19003798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAM 12 as a first-trimester maternal serum marker in screening for Down syndrome.
    Laigaard J; Spencer K; Christiansen M; Cowans NJ; Larsen SO; Pedersen BN; Wewer UM
    Prenat Diagn; 2006 Oct; 26(10):973-9. PubMed ID: 16892462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling Down syndrome screening performance using first-trimester serum markers.
    Koster MP; Wortelboer EJ; Stoutenbeek P; Visser GH; Schielen PC
    Ultrasound Obstet Gynecol; 2011 Aug; 38(2):134-9. PubMed ID: 21800388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses.
    Spencer K; Cowans NJ; Avgidou K; Molina F; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Jan; 31(1):15-9. PubMed ID: 17999381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system.
    Cowans NJ; Spencer K
    Prenat Diagn; 2007 Mar; 27(3):264-71. PubMed ID: 17278174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First trimester maternal serum analytes and second trimester uterine artery Doppler in the prediction of preeclampsia and fetal growth restriction.
    Yu N; Cui H; Chen X; Chang Y
    Taiwan J Obstet Gynecol; 2017 Jun; 56(3):358-361. PubMed ID: 28600048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early fetal growth, PAPP-A and free β-hCG in relation to risk of delivering a small-for-gestational age infant.
    Kirkegaard I; Henriksen TB; Uldbjerg N
    Ultrasound Obstet Gynecol; 2011 Mar; 37(3):341-7. PubMed ID: 20737455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal serum ADAM12 levels correlate with PAPP-A levels during the first trimester.
    Valinen Y; Peuhkurinen S; Järvelä IY; Laitinen P; Ryynanen M
    Gynecol Obstet Invest; 2010; 70(1):60-3. PubMed ID: 20197665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal serum ADAM12 (A disintegrin and metalloprotease) in chromosomally abnormal pregnancy at 11-13 weeks.
    Poon LC; Chelemen T; Minekawa R; Frisova V; Nicolaides KH
    Am J Obstet Gynecol; 2009 May; 200(5):508.e1-6. PubMed ID: 19285649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia.
    Wortelboer EJ; Koster MP; Cuckle HS; Stoutenbeek PH; Schielen PC; Visser GH
    BJOG; 2010 Oct; 117(11):1384-9. PubMed ID: 20840693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
    Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
    Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of birth weight by fetal crown-rump length and maternal serum levels of pregnancy-associated plasma protein-A in the first trimester.
    Leung TY; Sahota DS; Chan LW; Law LW; Fung TY; Leung TN; Lau TK
    Ultrasound Obstet Gynecol; 2008 Jan; 31(1):10-4. PubMed ID: 18098339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAM12 as a marker of trisomy 18 in the first and second trimester of pregnancy.
    Spencer K; Cowans NJ
    J Matern Fetal Neonatal Med; 2007 Sep; 20(9):645-50. PubMed ID: 17701664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-trimester maternal serum a disintegrin and metalloprotease 12 (ADAM12) and adverse pregnancy outcome.
    Poon LC; Chelemen T; Granvillano O; Pandeva I; Nicolaides KH
    Obstet Gynecol; 2008 Nov; 112(5):1082-90. PubMed ID: 18978109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First trimester serum tests for Down's syndrome screening.
    Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD011975. PubMed ID: 26617074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First trimester screening for trisomy 21 in gestational week 8-10 by ADAM12-S as a maternal serum marker.
    Tørring N; Ball S; Wright D; Sarkissian G; Guitton M; Darbouret B
    Reprod Biol Endocrinol; 2010 Oct; 8():129. PubMed ID: 21034452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of first-trimester serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A on the diagnosis of fetal growth restriction and small for gestational age infant.
    Montanari L; Alfei A; Albonico G; Moratti R; Arossa A; Beneventi F; Spinillo A
    Fetal Diagn Ther; 2009; 25(1):130-5. PubMed ID: 19279389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation.
    Poon LC; Zaragoza E; Akolekar R; Anagnostopoulos E; Nicolaides KH
    Prenat Diagn; 2008 Dec; 28(12):1110-5. PubMed ID: 19003787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of small-for-gestational-age neonates: screening by maternal biochemical markers at 30-34 weeks.
    Bakalis S; Gallo DM; Mendez O; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Aug; 46(2):208-15. PubMed ID: 25826797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
    Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.